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Abstract 23 
Our objective was to identify if changes in serum protein concentrations occur in 24 
hyperthyroidism and to assess their association with the development of azotaemia following 25 
treatment.  26 
Initially non-azotaemic hyperthyroid cats and healthy older cats were included. Serum 27 
concentrations of protein fractions were determined by agarose gel electrophoresis and 28 
compared between; hyperthyroid and control cats, initially non-azotaemic hyperthyroid cats 29 
which developed azotaemia in a 4 month follow up period (masked-azotaemic) and those which 30 
remained non-azotaemic, and hyperthyroid cats before and at the time of restoration of 31 
euthyroidism. Data are presented as median [25th, 75th percentile]. 32 
Hyperthyroid cats (n = 56) had higher serum α2 globulin concentrations (12.5 [10.9, 33 
13.1] g/L vs. 9.8 [3.0, 11.4] g/L; P < 0.001) and lower serum γ globulin concentrations (11.4 34 
[9.1, 13.3] g/L vs. 14.0 [12.4, 16.8] g/L; P = 0.001) than control cats (n = 26). Following 35 
treatment, serum total globulin concentration increased (from 38.6 [35.4, 42.8] g/L to 42.3 36 
[39.0, 45.7] g/L; P < 0.001), serum α2 globulin concentration decreased (from 12.5 [10.9, 13.9] 37 
g/L to 11.5 [10.1, 12.6] g/L; P < 0.001) and serum γ globulin concentration increased (from 38 
11.4 [9.0, 13.3] g/L to 14.0 [12.4, 16.8] g/L; P < 0.001). Serum concentrations of total globulin 39 
or globulin fractions were not significantly different between masked-azotaemic and non 40 
azotaemic groups. 41 
In conclusion, hyperthyroidism is associated with altered serum concentrations of the 42 
α2 and γ globulin fractions, however these changes were not associated with the development 43 
of azotaemic chronic kidney disease following treatment. 44 
 45 
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Introduction 48 
Chronic kidney disease (CKD) is a common co-morbidity in hyperthyroidism, 49 
however hyperthyroidism will complicate the diagnosis of CKD due to the consequent 50 
increase in glomerular filtration rate (GFR) (Adams et al. 1997) and decrease in body muscle 51 
mass (Shiel and Mooney 2007). Hence, hyperthyroidism decreases serum creatinine 52 
concentrations, which ‘masks’ concurrent azotaemic CKD in these patients. Some 53 
hyperthyroid cats with concurrent CKD only develop azotaemia after treatment, once GFR 54 
and body muscle mass have returned to normal (for the cat). Identification of hyperthyroid 55 
cats with concurrent, but masked, CKD prior to treatment of hyperthyroidism would be 56 
beneficial because it would allow the institution of appropriate treatment strategies for CKD 57 
at an earlier time point. 58 
 59 
Several studies have attempted to identify biomarkers of CKD in hyperthyroidism 60 
(Lapointe et al. 2008; Riensche et al. 2008; van Hoek et al. 2009a; van Hoek et al. 2009b; 61 
Williams et al. 2010; Williams et al. 2016), however, no single reliable test has been reported. 62 
In one previous study of 300 hyperthyroid cats, only (higher) plasma creatinine 63 
concentrations and (lower) plasma globulin concentrations were independent predictors of the 64 
development of azotaemia within 240 days of diagnosis of hyperthyroidism (Williams et al. 65 
2010). These data suggest that plasma total globulin concentration, or the plasma 66 
concentration of a component of the globulin fraction, could be a marker of concurrent, but 67 
masked, azotaemic CKD in hyperthyroidism. 68 
 69 
Agarose gel electrophoresis (AGE) is a technique which separates serum proteins into 70 
4-6 major groups of one or more bands, based on the ability of the proteins to migrate 71 
through the agarose gel when an electrical field is applied. The distance of migration is 72 
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dependent on the electrical charge, mass and shape of the protein. By utilising this technique, 73 
the serum concentrations of individual globulin fractions can be elucidated, which could help 74 
to determine which serum protein is associated with the presence of concurrent, but masked, 75 
azotaemic CKD in hyperthyroid cats.  76 
 77 
The first aim of this study was to establish if the results of our previous study were 78 
repeatable in an independent group of cats, and if so, to identify if any individual globulin 79 
fraction associated with the presence of concurrent, but masked, azotaemic CKD in 80 
hyperthyroid cats, since this could provide a novel biomarker for CKD in these cases. The 81 
second aim was to investigate if changes in serum protein concentrations occur in hyperthyroid 82 
cats (by comparison of serum concentrations of individual globulin fractions between 83 
hyperthyroid cats and healthy older cats, and before and after treatment of hyperthyroidism), 84 
since changes in serum concentrations of some proteins have been reported in animal models 85 
of hyperthyroidism previously (Farthing et al. 1960, Griffin and Miller 1973). 86 
 87 
Materials and methods 88 
Hyperthyroid cats seen between March 2010 and June 2013 at two first opinion 89 
practices in London were included in the study. All were non-azotaemic (plasma creatinine 90 
concentration < 177 µmol/L) at the time of presentation. Cats with other known significant 91 
systemic disorders except hypertension (based on clinical examination, serum biochemistry 92 
and urinalysis), including significant systemic inflammatory disease (for example 93 
inflammatory bowel disease) were excluded. Included cats were not, however, screened for 94 
FeLV or FIV infection. Following informed consent by the owner, blood and urine samples 95 
were taken from the cats as part of a geriatric screening programme (Royal Veterinary College 96 
Ethics and Welfare Committee approval number and date; URN 20131258, 2nd December 97 
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2013). Blood was obtained by jugular venepuncture, placed in heparinised or non-98 
anticoagulated tubes, and stored at 4 oC until sample processing (within 6 h). Urine samples 99 
were taken by cystocentesis. Biochemical analysis was performed by IDEXX Laboratories 100 
(Wetherby, UK) using heparinised plasma. Residual serum was stored at -80 oC and 101 
subsequently submitted to Central Diagnostic Services (Cambridge, UK) for batch 102 
measurement of serum TT4 by enzyme immunoassay (Williams and Archer 2016), serum total 103 
protein by biuret reaction, and AGE analysis. Urine specific gravity (USG) determination (by 104 
refractometry), urine dipstick, and urine sediment analysis was also performed in-house. The 105 
presence of bacteriuria or pyuria (>5 white blood cells per 1000x field) was an exclusion 106 
criterion for the study.  107 
 108 
 All hyperthyroid cats were treated with the aim of attaining a plasma TT4 < 40 109 
nmol/L. Cats were initially treated with anti-thyroid medication (usually methimazole), with 110 
some animals also undergoing thyroidectomy following initial stabilisation. Cats were re-111 
examined and plasma TT4 repeated every 4 weeks until restoration of euthyroidism was 112 
documented (defined as a plasma TT4 < 40 nmol/L). Once euthyroidism had been achieved, 113 
the cats were monitored for a 4 month period, with further blood and urine samples taken at 114 
the end of this monitoring period. Cats were defined as masked-azotaemic if they had a 115 
plasma creatinine concentration > 177 µmol/L with a concurrent USG < 1.035 at the end of 116 
this four month monitoring period. Cats with persistent azotaemia without obvious evidence 117 
of dehydration (pre-renal azotaemia) were also classified as masked-azotaemic. All other 118 
hyperthyroid cats were classified as non-azotaemic. Samples taken at the time of diagnosis of 119 
hyperthyroidism and at the time of first documentation of euthyroidism were used for AGE 120 
analysis.  121 
 122 
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 Healthy older cats that presented to three first opinion practices in the South-East of 123 
England between March 2013 and April 2015 were also included. These cats all had no 124 
clinical history of disease (except the presence of tartar with or without associated gingivitis, 125 
or degenerative joint disease), no significant haematological or biochemical abnormalities, 126 
were on no long term medications (except anti-parasitic medications) and were at least 8 127 
years old. Included cats were not, however, screened for FeLV or FIV. Blood and urine 128 
samples were obtained by practitioners following informed consent as part of a geriatric 129 
screening programme (Ethics and Welfare Committee of the Department of Veterinary 130 
Medicine at the University of Cambridge approval number and date; CR56, 4th August 2012) 131 
and submitted to Central Diagnostic Services within 3 days of sampling. Full haematology, 132 
serum biochemistry (including TT4 by enzyme immunoassay) and urinalysis (including urine 133 
protein:creatinine ratio [UPC]) was performed, and any animals with azotaemia (defined as a 134 
serum creatinine concentration > 153 µmol/L), proteinuria (defined as UPC >0.4), borderline 135 
or overt hyperthyroidism (defined as a serum TT4 > 40 nmol/L), bacteriuria, pyuria (defined 136 
as > 5 white blood cells per 1000x field) or other significant haematological or biochemical 137 
abnormalities were excluded from the cohort. Residual serum was stored at -80C until batch 138 
AGE analysis.  139 
 140 
Agarose gel electrophoresis 141 
AGE was performed with agarose gels (HydraGel 7 β1β2, Sebia), according to the 142 
manufacturer’s instructions. A normal cat control sample was run on each gel and paired 143 
samples from each individual hyperthyroid cat (hyperthyroid and euthyroid time points) were 144 
run on the same gel. The electrophoretograms were read using a densitometer and Phoresis 145 
software (Sebia). Densitometric readings from each lane of the gel were displayed as a curve, 146 
and the various bands (represented by peaks on the curve) were resolved manually by one 147 
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investigator (TW) with the percentage of albumin and the individual globulin fractions 148 
calculated based on the area under each part of the curve divided by the total area under the 149 
curve. Absolute concentrations of the proteins were determined by multiplication of the 150 
percentage of that protein by the serum total protein concentration (determined by biuret 151 
reaction).  152 
 153 
Statistical analysis 154 
Statistical analysis was performed with SPSS v21.0 (IBM). The Mann Whitney U test 155 
was used to compare serum concentrations of total protein, albumin, total globulin and the 156 
individual globulin fractions between; hyperthyroid and healthy older cats, and masked-157 
azotaemic and non-azotaemic hyperthyroid cats. The Wilcoxon signed rank test was used to 158 
compare serum concentrations of proteins in hyperthyroid cats before treatment and at the time 159 
of establishment of euthyroidism. Correlations between baseline serum concentrations of total 160 
protein, albumin, globulin and the individual globulin fractions and age, serum concentrations 161 
of creatinine and TT4, were assessed by Spearman’s correlation co-efficient. Correlations were 162 
classified as weak if rs < 0.5, moderate if rs was 0.5-0.7, and strong if  rs > 0.7. The proportion 163 
of cats in the hyperthyroid and healthy older cat groups which had serum concentrations of the 164 
various protein fractions outside of the reference intervals reported in a previous study (Taylor 165 
et al. 2010) were compared using the Fisher’s Exact test. Data are presented as median [25th, 166 
75th percentile] and statistical significance was defined as P < 0.05. 167 
 168 
Results 169 
Fifty six hyperthyroid cats and 26 healthy older cats were included in the study. In the 170 
hyperthyroid group, 21 cats developed azotaemia during the follow up period (masked-171 
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azotaemic group) and 35 cats were classified as non-azotaemic. Selected clinicopathological 172 
data for the hyperthyroid and healthy older cat groups are shown in Table 1.  173 
 174 
The comparison of serum concentrations of total protein, albumin, total globulins and 175 
globulin fractions between the masked-azotaemic and non-azotaemic hyperthyroid groups are 176 
shown in Table 2. Serum total protein concentration was higher in masked-azotaemic 177 
hyperthyroid cats compared to those which remained non-azotaemic (P = 0.049), however no 178 
significant differences in the serum concentrations of α1, α2, β, γ or total globulin were evident 179 
between the masked-azotaemic and non azotaemic groups. 180 
 181 
Serum concentrations of total protein, albumin, total globulins and globulin fractions in 182 
the hyperthyroid and healthy older cat groups are summarised in Table 1. Hyperthyroid cats 183 
had significantly higher serum α2 globulin concentrations (P < 0.001, Figure 1) and lower serum 184 
γ globulin concentrations (P = 0.001, Figure 2) than healthy older cats. The proportion of cats 185 
with a serum α2 globulin concentration above the reference interval reported in a previous study 186 
(Taylor et al. 2010) was significantly greater in the hyperthyroid group compared to the healthy 187 
older cat group (50/56 vs. 11/26; P<0.001). All cats had a serum γ globulin concentration within 188 
or above the previously reported reference interval, however there was no significant difference 189 
in the proportion of cats with a serum γ globulin concentration above the reference interval 190 
between the hyperthyroid and healthy older cat groups (4/56 vs. 3/26 respectively; P=0.673). 191 
Hyperthyroid cats also had significantly lower serum albumin concentrations than healthy older 192 
cats (P = 0.008), however the proportion of cats with a serum albumin concentration below the 193 
reference interval reported in a previous study (Taylor et al. 2010) was not significantly 194 
different between the hyperthyroid and healthy older cat groups (6/56 vs. 4/26 respectively; 195 
P=0.718). In hyperthyroid cats (at baseline), serum γ globulin concentrations were weakly 196 
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positively correlated with plasma creatinine concentration (rs = 0.356, n = 54; P = 0.008) and 197 
weakly negatively correlated with TT4 (rs = -0.415, n = 56; P < 0.001). No parameter was 198 
correlated with age in the hyperthyroid group alone, however when healthy older cats were 199 
included in the analysis, serum albumin concentration was weakly negatively associated with 200 
age (rs = -0.236, n = 80; P = 0.035). When only healthy older cats were considered, a moderate 201 
positive correlation between age and serum γ globulin concentrations was evident (rs = 0.522, 202 
n = 25; P = 0.008). 203 
 204 
Changes in serum concentrations of total protein, albumin, total globulins and globulin 205 
fractions in the hyperthyroid group after treatment (n = 55) are shown in Table 3. Following 206 
treatment of hyperthyroidism, serum total globulin concentration increased (P < 0.001), serum 207 
α1 globulin concentration increased (P = 0.031), serum α2 globulin concentration decreased (P 208 
< 0.001, Figure 3) and serum γ globulin concentration increased (P < 0.001, Figure 4). Serum 209 
concentrations of albumin did not change significantly following treatment (P = 0.378). 210 
 211 
Discussion 212 
The primary aim of the current study was to identify potential biomarkers of CKD in 213 
hyperthyroidism. In a previous study, decreased plasma globulin concentrations were 214 
independent predictors of the development of azotaemia within 240 days of diagnosis of 215 
hyperthyroidism (Williams et al. 2010), however despite the evidence of altered serum 216 
protein concentrations in hyperthyroid cats in this study, no association between the serum 217 
concentrations of total globulin or the globulin fractions and the development of azotaemic 218 
CKD following treatment of hyperthyroidism was identified. Total protein concentrations 219 
were significantly higher in cats with concurrent, but masked, azotaemic CKD than cats 220 
which remained non-azotaemic, which is in contrast to the previously reported study 221 
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(Williams et al. 2010). This discrepancy could reflect a type I statistical error in this or the 222 
previous study, or could reflect differences in the sample types used. The present study 223 
investigated serum globulin concentrations, whereas the previous study reported the plasma 224 
globulin concentrations. The only difference between these samples would be the absence or 225 
presence of fibrinogen respectively, however it is possible that changes in circulating 226 
fibrinogen concentrations could account for the observed differences between this and the 227 
previous study (Williams et al. 2010). Elevated serum fibrinogen concentrations occur in 228 
human hyperthyroid patients (Dörr et al. 2006; Popławska-Kita et al. 2013), therefore 229 
evaluation of serum fibrinogen concentrations and their association with the development of 230 
azotaemic CKD following treatment of hyperthyroidism could be warranted. Whilst it could 231 
be speculated that the higher total protein concentrations observed in cats in the masked-232 
azotaemic group in this study reflects lower extracellular fluid volume of those animals, 233 
perhaps secondary to concurrent polyuria associated with CKD, this is considered unlikely 234 
given the lack of a concurrent increase in serum albumin concentration in these cats. 235 
Furthermore, a recent study suggested that extracellular fluid volume is not different between 236 
non-hyperthyroid cats with and without azotaemic CKD (Finch et al. 2015). 237 
 238 
The second aim of this study was to identify if alterations in serum globulin 239 
concentrations were present in hyperthyroid cats. This is the first study to report a number of 240 
changes in the serum concentrations of globulin fractions in hyperthyroid cats when 241 
compared with healthy older cats, which mostly resolved following treatment, thus 242 
suggesting that hyperthyroidism causes changes in the concentrations of some of the globulin 243 
fractions as determined by AGE. However, the observed changes in serum concentrations of 244 
the globulin fractions in hyperthyroid cats were mild compared with the more marked 245 
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changes that would be expected in inflammatory diseases (which were not fully excluded in 246 
cats included in this study). 247 
 248 
In the present study, serum concentrations of α2 globulins were higher in hyperthyroid 249 
cats than healthy older cats, and they also decreased following successful treatment of 250 
hyperthyroidism, suggesting that hyperthyroidism increases serum α2 globulin concentrations. 251 
Proteins that will migrate in the α2 globulin band on AGE include α2 macroglobulin and 252 
haptoglobin (Baker and Valli 1988). It is possible that the increased serum α2 globulin 253 
concentrations observed in feline hyperthyroidism are secondary to increased hepatic 254 
synthesis of haptoglobin, as has been demonstrated in rats with experimentally induced 255 
hyperthyroidism (Griffin and Miller 1973), however further studies utilising methods that can 256 
specifically measure serum haptoglobin, for example ELISA (Kajikawa et al. 1999), would 257 
be necessary to determine this.  258 
 259 
Hyperthyroid cats in the present study also had significantly lower serum γ globulin 260 
concentrations, which increased following successful treatment of hyperthyroidism. These 261 
results also suggest that hyperthyroidism causes a decrease in serum γ globulin 262 
concentrations in cats. Proteins that migrate in the γ globulin band include IgG and IgM 263 
(Gerou-Ferriani et al. 2011). In one previous experimental study, the catabolism of 131I-264 
labelled homologous γ globulins (IgG) was increased in hyperthyroid rats (Farthing et al. 265 
1960), therefore it is possible that the same process occurs in hyperthyroid cats, however 266 
further evaluation of serum IgG concentrations, by IgG specific techniques, would be 267 
necessary to confirm if the changes in serum γ globulin concentrations are secondary to 268 
changes in IgG. Furthermore, in this study, increased urinary or gastrointestinal losses of 269 
immunoglobulin were not excluded.   270 
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 271 
The clinical significance of the observed changes in serum concentrations of specific 272 
globulin fractions in hyperthyroid cats is unclear, but given the relatively mild changes 273 
observed in the electrophoretic fraction then they are unlikely to be clinically relevant.  274 
 275 
Serum albumin concentrations were lower in hyperthyroid cats than in healthy older 276 
cats, but did not change following treatment. Although hyperthyroidism accelerates albumin 277 
turnover in human patients and rats (Kekki 1964; Blomstedt and Likjedahl 1967), altered 278 
serum albumin concentrations in hyperthyroid human patients have not been demonstrated 279 
(Blomstedt and Likjedahl 1967). In the current study, hyperthyroid cats were significantly 280 
older than the healthy older cat group, therefore the lower serum albumin concentration in 281 
hyperthyroid cats might reflect reduced albumin synthesis associated with chronic 282 
inflammatory diseases (such as dental disease), which are likely to be more common in older 283 
cats. The significant positive correlation between serum γ globulin concentrations, which are 284 
also associated with inflammatory disease, and age that was identified in the healthy older 285 
cats would support this hypothesis. Alternatively, the lower serum albumin concentrations in 286 
hyperthyroid cats could reflect increased urinary protein loss, since hyperthyroidism is 287 
associated with proteinuria (van Hoek et al. 2009a; Williams et al. 2010). 288 
 289 
This study had a number of limitations; firstly the healthy older cat and hyperthyroid 290 
groups were not age matched, which might have confounded some of the comparisons in the 291 
cross sectional analysis, however a strength of the study was that the hyperthyroid cats were 292 
evaluated after successful treatment which enabled the determination of which serum 293 
globulin fractions might be influenced by hyperthyroidism per se. Secondly, haematological 294 
evaluation was not performed in hyperthyroid cats, due to financial restrictions at the time of 295 
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sampling, however cats with suspected co-morbidities (except for ‘masked’ CKD and 296 
hypertension) were excluded from the study. We also did not exclude all possible 297 
inflammatory causes of altered serum protein concentrations, most notably FeLV and FIV 298 
infection, in the cats included in this study, which could have confounded our results given 299 
the effect of these conditions on the electrophoretogram (Hofmann-Lehmann et al. 1997). 300 
However, the prevalence of FeLV and FIV in our population is likely to be low (Hosie et al. 301 
1989; Murray et al. 2009; Juvet et al. 2011), therefore we do not feel that this would have 302 
significantly altered our results. Furthermore, the electrophoretic fractions will be mostly 303 
influenced by the presence of concurrent (usually inflammatory) diseases, and therefore we 304 
cannot fully exclude the possibility that the differences in the globulin fractions observed 305 
between the hyperthyroid and healthy groups in the present study could actually reflect 306 
differences in the prevalence of concurrent diseases (that influence the electrophoretogram) 307 
between the two groups. Serum urea and creatinine concentrations for the healthy and 308 
hyperthyroid groups were also determined in different laboratories, although azotaemia for 309 
each group was defined based on a value above the laboratory reference interval specific to 310 
the testing laboratory, as is recommended. In addition, some of the healthy older cats and 311 
non-azotaemic hyperthyroid cats could have had subclinical, non-azotaemic CKD, which 312 
could not be diagnosed without direct assessment of glomerular filtration rate. Serum protein 313 
electrophoresis (SPE) is also a relatively insensitive way of determining the changes in serum 314 
concentrations of the various components of the globulin fraction, and it is possible that 315 
changes in the serum concentrations of one or more individual components of the globulin 316 
fraction were associated with the development of azotaemic CKD following treatment of 317 
hyperthyroidism, but the abundance of these proteins was too low to be detected by SPE. 318 
Further evaluation of specific acute phase proteins and immunoglobulin concentrations in 319 
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hyperthyroid cats and their association with the presence of concurrent, but masked, CKD 320 
would be necessary to further evaluate this possibility.  321 
 322 
Conclusions 323 
Hyperthyroid cats demonstrate mild changes in the serum concentrations of some 324 
globulin fractions, most notably in the serum α2 and γ globulin fractions, when compared with 325 
old non-hyperthyroid cats, however the cause of these changes was not identified in the 326 
current study. The mild changes in the globulin fractions are also unlikely to be of clinical 327 
relevance in most cases. Serum concentrations of total protein, total globulin or globulin 328 
fractions were not associated with the presence of concurrent, but masked, azotaemic CKD in 329 
hyperthyroid cats, suggesting that serum globulin concentrations are not a reliable marker of 330 
concurrent CKD in hyperthyroidism. 331 
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Table 1 440 
Selected baseline clinicopathological data and serum concentrations of total protein, albumin, 441 
total globulin and globulin fractions in hyperthyroid cats (n=56) and healthy older cats 442 
(n=26).  443 
Variable Hyperthyroida Healthy older catsa Significanceb 
  
Age (years) 14.8 [12.8, 16.1] 12.0 [10.4, 16.1] <0.001 
Serum total thyroxine concentration 
(nmol/L) 
104 [68, 152] 28 [18, 27] <0.001 
Serum/plasma urea concentration 
(mmol/L) 
5.0 [4.1, 6.2] 4.6 [4.1, 5.6] 0.576 
Serum/plasma creatinine concentration 
(mmol/L) 
106.1 [88.4, 123.8] 132.6 [114.9, 141.4] <0.001 
Serum total protein concentration (g/L) 69.7 [65.9, 73.4] 71.5 [69.0, 76.0] 0.106 
Serum albumin concentration (g/L) 29.9 [28.6, 32.0] 33.0 [29.0, 35.0] 0.006 
Serum total globulin concentration (g/L) 38.5 [35.5, 42.8] 38.0 [35.8, 43.0] 0.858 
Serum α1 globulin concentration (g/L) 5.9 [5.1, 6.4] 5.9 [4.6, 6.7] 0.854 
Serum α2 globulin concentration (g/L) 12.5 [10.9, 13.9] 9.8 [9.0, 11.4] <0.001 
Serum β globulin concentration (g/L) 5.8 [4.9, 6.8] 5.6 [5.0, 6.8] 0.936 
Serum γ globulin concentration 11.4 [9.1, 13.3] 14.0 [12.4, 16.8] 0.001 
    
a Data are presented as median [25th, 75th percentiles].  444 
b Mann Whitney U test was used to compare values in hyperthyroid and healthy older cat 445 
groups. 446 
 447 
448 
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Table 2 449 
Comparison of serum concentrations of total protein, albumin, total globulin and globulin 450 
fractions between initially non-azotaemic hyperthyroid cats which develop azotaemic chronic 451 
kidney disease within four months of establishment of euthyroidism (masked-azotaemic, 452 
n=21) and hyperthyroid cats that remain non-azotaemic following treatment (n=35).  453 
Variable Masked-
azotaemica 
Non-azotaemica Significanceb 
  
Serum total protein concentration (g/L)c 70.8 [67.2, 75.9] 68.1 [65.5, 72.2] 0.049 
Serum albumin concentration (g/L)c 30.7 [28.0, 32.1] 29.6 [29.0, 32.0] 0.806 
Serum total globulin concentration (g/L)c 39.8 [37.3, 45.8] 37.9 [33.8, 42.4] 0.104 
Serum α1 globulin concentration (g/L)c 5.8 [5.0, 6.3] 6.0 [5.2, 6.8] 0.326 
Serum α2 globulin concentration (g/L)c 13.0 [11.7, 14.4] 12.2 [10.9, 13.7] 0.426 
Serum β globulin concentration (g/L)c 5.7 [5.3, 6.4] 5.9 [4.8, 7.0] 0.912 
Serum γ globulin concentrationc 12.3 [9.5, 17.4] 10.8 [8.7, 12.9] 0.092 
 
a Data are presented as median [25th, 75th percentiles].  454 
b Mann Whitney U test was used to compare values in masked-azotaemic and non-azotaemic 455 
hyperthyroid cats. 456 
c Total protein was determined by biuret reaction and all other protein concentrations were 457 
determined by agarose gel electrophoresis. 458 
 459 
 460 
 461 
 462 
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Table 3 463 
Changes in serum concentrations of total protein, albumin, total globulin and globulin 464 
fractions in hyperthyroid cats before treatment and at time of establishment of euthyroidism 465 
(n=55). Total protein was determined by biuret reaction and all other protein concentrations 466 
were determined by agarose gel electrophoresis. 467 
Variable Before 
treatmenta 
Establishment of 
euthyroidisma,b 
Significancec 
 
Serum total protein concentration 
(g/L) 
69.9 [65.9, 73.5] 72.6 [69.6, 76.6] <0.001 
 
Serum albumin concentration (g/L) 29.6 [28.6, 32.0] 30.3 [27.9, 32.5] 0.378 
Serum total globulin concentration 
(g/L) 
38.6 [35.4, 42.8] 42.3 [39.0, 45.7] <0.001 
Serum α1 globulin concentration (g/L) 5.9 [5.0, 6.4] 6.0 [5.3, 7.0] 0.031 
Serum α2 globulin concentration (g/L) 12.5 [10.9, 13.9] 11.5 [10.1, 12.6] <0.001 
Serum β globulin concentration (g/L) 5.7 [4.9, 6.8] 5.6 [4.7, 6.5] 0.626 
Serum γ globulin concentration 11.4 [9.0, 13.3] 14.5 [12.0, 18.4] <0.001 
 468 
a Data are presented as median [25th, 75th percentiles].  469 
b Time between before treatment and establishment of euthyroidism time points was 42 [35, 470 
68] days.  471 
c Wilcoxon signed rank test was used to compare values in hyperthyroid cats before treatment 472 
and at time of establishment of euthyroidism.473 
20 
 
Figure legends 474 
Figure 1. Box and whisker plots of serum α2 globulin concentrations in a group of untreated 475 
hyperthyroid cats (n=56) and a group of healthy older cats (n=26). Whiskers represent the 5th 476 
and 95th percentiles and circles represent outliers. Serum α2 globulin concentrations were 477 
higher in hyperthyroid cats compared to healthy older cats (P<0.001). 478 
 479 
  480 
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Figure 2. Box and whisker plots of serum γ globulin concentrations in a group of untreated 481 
hyperthyroid cats (n=56) and a group of healthy older cats (n=26). Whiskers represent the 5th 482 
and 95th percentiles and circles represent outliers. Serum γ globulin concentrations were 483 
higher in hyperthyroid cats compared to healthy older cats (P=0.001). 484 
 485 
 486 
  487 
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Figure 3. Line chart showing serum α2 globulin concentrations in hyperthyroid cats before 488 
treatment (pre-treatment) and at time of establishment of euthyroidism (post-treatment). 489 
Serum α2 globulin concentrations decreased significantly following treatment (P<0.001). 490 
 491 
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Figure 4. Line chart showing serum γ globulin concentrations in hyperthyroid cats before 492 
treatment (pre-treatment) and at time of establishment of euthyroidism (post-treatment). 493 
Serum γ globulin concentrations increased significantly following treatment (P<0.001). 494 
 495 
